FDA Investigator: Bo Chi

- Bo Chi first started conducting FDA inspections in 2007, with the last inspection in 2023. Over that time, Bo Chi has conducted 44 inspections at 37 companies across 39 sites.

Documents

FDA 483 Novartis d.o.o., Menges | 2023

Out-of-stock
Bo Chi
Human Drugs Form 483

FDA 483 Wuxi Biologics Co Ltd, Wuxi | 2023

Out-of-stock
Bo Chi
Human Drugs Form 483

FDA 483 Seibersdorf Labor GmbH, Seibersdorf | 2022

Out-of-stock
Bo Chi
Human Drugs Form 483

FDA 483 Nang Kuang Pharmaceutical Co., Ltd., Tainan City | 2022

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Takeda Pharmaceuticals U.S.A., Brooklyn Park | 2020

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Merz Pharma GmbH & Co., KGaA, Dessau-Rosslau | 2019

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Biogen Idec (Denmark) Manufacturing ApS, Hillerod | 2019

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Patheon Biologics LLC, Saint Louis | 2018

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Exelead, Inc., Indianapolis | 2018

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Amgen, Inc., Thousand Oaks | 2018

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Chugai Pharmaceutical Co., Ltd., Kita | 2017

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Wuxi Apptec Biopharmaceuticals Co Ltd, Wuxi | 2017

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza Biologics Porrino, O Porrino (Casco Urbano) | 2016

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza Biologics Porrino, O Porrino (Casco Urbano) | 2016

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Amgen, Inc., Thousand Oaks | 2016

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza Biologics, Inc., Portsmouth | 2015

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Celltrion Inc., Incheon City | 2015

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Celltrion Inc., Incheon City | 2015

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Eli Lilly SA Irish Branch, Kinsale, County Cork | 2014

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Biogen Idec, Inc., Cambridge | 2013

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Biogen, Cambridge | 2013

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Human Genome Sciences Inc, Rockville | 2013

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza AG, Visp | 2012

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Genentech, Inc., Hillsboro | 2012

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Genentech, Inc., Vacaville | 2012

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Roche Diagnostics GmbH, Penzberg | 2012

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Abbvie Biotechnology Ltd., Barceloneta | 2011

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Piramal Healthcare UK Ltd., Grangemouth | 2011

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Health Protection Agency, Salisbury | 2011

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Roche Singapore Technical Operations Pte. Ltd., Singapore | 2010

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Merz Group Services GmbH, Dessau-Rosslau | 2009

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lab Of Pharm.& Tox (dup Cf#, See 9610766, Hamburg | 2009

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Alexion Pharmaceuticals, Inc., Smithfield | 2009

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Human Genome Sciences Inc, Rockville | 2009

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza Biologics Plc, Slough | 2009

Out-of-stock
Bo Chi
Human Drug Form 483

FDA 483 Lonza Biologics Plc, Wokingham | 2009

Out-of-stock
Bo Chi
Human Drug Form 483